Partnering with CROs and using a blinded independent central review can increase trial success.
John F. Tomera
Advertisement
Articles by John F. Tomera
How independent endpoint assessment committees can overcome imaging limitations.
Advertisement
Latest Updated Articles
Enrollment: More Than NumbersPublished: February 1st 2012 | Updated:
A Team ApproachPublished: May 1st 2010 | Updated:
Advertisement
Advertisement
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
